Hormone replacement therapy is associated with increased C-reactive protein in women with Type 2 diabetes in the Diabetes Heart Study
This cohort study aimed to explore the impact of hormone replacement therapy (HRT) on C-reactive protein (CRP) levels in post-menopausal women with Type 2 diabetes (T2DM), highlighting that HRT use was associated with significantly elevated CRP levels, a marker of inflammation linked to cardiovascular disease. The study included 327 women,